BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29166018)

  • 1. Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques.
    Di Lello P; Pastor R; Murray JM; Blake RA; Cohen F; Crawford TD; Drobnick J; Drummond J; Kategaya L; Kleinheinz T; Maurer T; Rougé L; Zhao X; Wertz I; Ndubaku C; Tsui V
    J Med Chem; 2017 Dec; 60(24):10056-10070. PubMed ID: 29166018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Integrated in silico Approach and in vitro Study for the Discovery of Small-Molecule USP7 Inhibitors as Potential Cancer Therapies.
    Kanan D; Kanan T; Dogan B; Orhan MD; Avsar T; Durdagi S
    ChemMedChem; 2021 Feb; 16(3):555-567. PubMed ID: 33063944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of USP7 small-molecule allosteric inhibitors.
    Engström O; Belda O; Kullman-Magnusson M; Rapp M; Böhm K; Paul R; Henderson I; Derbyshire D; Karlström S; Parkes KEB; Zhao H
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127471. PubMed ID: 32781219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies.
    Wu J; Kumar S; Wang F; Wang H; Chen L; Arsenault P; Mattern M; Weinstock J
    J Med Chem; 2018 Jan; 61(2):422-443. PubMed ID: 28768102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP7 small-molecule inhibitors interfere with ubiquitin binding.
    Kategaya L; Di Lello P; Rougé L; Pastor R; Clark KR; Drummond J; Kleinheinz T; Lin E; Upton JP; Prakash S; Heideker J; McCleland M; Ritorto MS; Alessi DR; Trost M; Bainbridge TW; Kwok MCM; Ma TP; Stiffler Z; Brasher B; Tang Y; Jaishankar P; Hearn BR; Renslo AR; Arkin MR; Cohen F; Yu K; Peale F; Gnad F; Chang MT; Klijn C; Blackwood E; Martin SE; Forrest WF; Ernst JA; Ndubaku C; Wang X; Beresini MH; Tsui V; Schwerdtfeger C; Blake RA; Murray J; Maurer T; Wertz IE
    Nature; 2017 Oct; 550(7677):534-538. PubMed ID: 29045385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counting on Fragment Based Drug Design Approach for Drug Discovery.
    Kashyap A; Singh PK; Silakari O
    Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectively Modulating Conformational States of USP7 Catalytic Domain for Activation.
    Özen A; Rougé L; Bashore C; Hearn BR; Skelton NJ; Dueber EC
    Structure; 2018 Jan; 26(1):72-84.e7. PubMed ID: 29249604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity.
    Leger PR; Hu DX; Biannic B; Bui M; Han X; Karbarz E; Maung J; Okano A; Osipov M; Shibuya GM; Young K; Higgs C; Abraham B; Bradford D; Cho C; Colas C; Jacobson S; Ohol YM; Pookot D; Rana P; Sanchez J; Shah N; Sun M; Wong S; Brockstedt DG; Kassner PD; Schwarz JB; Wustrow DJ
    J Med Chem; 2020 May; 63(10):5398-5420. PubMed ID: 32302140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.
    Reverdy C; Conrath S; Lopez R; Planquette C; Atmanene C; Collura V; Harpon J; Battaglia V; Vivat V; Sippl W; Colland F
    Chem Biol; 2012 Apr; 19(4):467-77. PubMed ID: 22520753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy.
    Harakandi C; Nininahazwe L; Xu H; Liu B; He C; Zheng YC; Zhang H
    Bioorg Chem; 2021 Nov; 116():105273. PubMed ID: 34474304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.
    Gavory G; O'Dowd CR; Helm MD; Flasz J; Arkoudis E; Dossang A; Hughes C; Cassidy E; McClelland K; Odrzywol E; Page N; Barker O; Miel H; Harrison T
    Nat Chem Biol; 2018 Feb; 14(2):118-125. PubMed ID: 29200206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors.
    Li P; Liu Y; Yang H; Liu HM
    Eur J Med Chem; 2021 Apr; 216():113291. PubMed ID: 33684824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms.
    Pozhidaeva A; Valles G; Wang F; Wu J; Sterner DE; Nguyen P; Weinstock J; Kumar KGS; Kanyo J; Wright D; Bezsonova I
    Cell Chem Biol; 2017 Dec; 24(12):1501-1512.e5. PubMed ID: 29056420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors.
    Li P; Liu HM
    Eur J Med Chem; 2020 Apr; 191():112107. PubMed ID: 32092586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyanopyrrolidine Inhibitors of Ubiquitin Specific Protease 7 Mediate Desulfhydration of the Active-Site Cysteine.
    Bashore C; Jaishankar P; Skelton NJ; Fuhrmann J; Hearn BR; Liu PS; Renslo AR; Dueber EC
    ACS Chem Biol; 2020 Jun; 15(6):1392-1400. PubMed ID: 32302100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP7: Structure, substrate specificity, and inhibition.
    Pozhidaeva A; Bezsonova I
    DNA Repair (Amst); 2019 Apr; 76():30-39. PubMed ID: 30807924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-benzylpiperidinol derivatives as novel USP7 inhibitors: Structure-activity relationships and X-ray crystallographic studies.
    Li M; Liu S; Chen H; Zhou X; Zhou J; Zhou S; Yuan H; Xu QL; Liu J; Cheng K; Sun H; Wang Y; Chen C; Wen X
    Eur J Med Chem; 2020 Aug; 199():112279. PubMed ID: 32497973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP7: Target Validation and Drug Discovery for Cancer Therapy.
    Zhou J; Wang J; Chen C; Yuan H; Wen X; Sun H
    Med Chem; 2018; 14(1):3-18. PubMed ID: 29065837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors.
    Wyss DF; Wang YS; Eaton HL; Strickland C; Voigt JH; Zhu Z; Stamford AW
    Top Curr Chem; 2012; 317():83-114. PubMed ID: 21647837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade.
    Wang Y; Jiang Y; Ding S; Li J; Song N; Ren Y; Hong D; Wu C; Li B; Wang F; He W; Wang J; Mei Z
    Cell Res; 2018 Dec; 28(12):1186-1194. PubMed ID: 30254335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.